Tailored Therapy for Helicobacter Pylori Treatment in Patients With Penicillin Allergy
Status:
Completed
Trial end date:
2019-09-30
Target enrollment:
Participant gender:
Summary
Increasing drug resistance presents a significant challenge to the efficacies of common
empiric eradication regimens for Helicobacter pylori treatment in the mainland of China.
Tailored therapy may be the best choice to achieve good efficacy, especially in patients with
penicillin allergy. Few studies had evaluated the patients with penicillin allergy.This study
is designed to evaluate the efficacy and safety of antibiotic sensitivity-based tailored
therapy for Helicobacter pylori treatment in the patients with penicillin allergy.